期刊
CHEST
卷 143, 期 2, 页码 511-523出版社
ELSEVIER
DOI: 10.1378/chest.12-0412
关键词
-
资金
- Chiesi Farmaceutici SpA
- Amgen Inc
- Asmacure Ltee
- AstraZeneca
- Genentech Inc.
- GlaxoSmithKline plc
- Takeda Pharmaceuticals International GmbH
- Aerocrine
- Genentech Inc
- Merck Co
- National Institute of Allergy and Infectious Diseases, National Institutes of Health
- National Heart, Lung, and Blood Institute, National Institutes of Health
The goal of asthma management is to achieve disease control; however, despite the availability of effective and safe medications, for many patients asthma remains uncontrolled. One reason for this is the fear of long-term side effects from the regular use of inhaled corticosteroids (ICSs). Adverse effects of poorly controlled asthma (for example, obesity, pneumonia, and risks to the fetus) can be perceived as side effects of ICSs. Poorly controlled asthma adversely affects children's cardiovascular fitness, while children with well-controlled asthma perform at the same level as their peers. Children with uncontrolled asthma also have a higher frequency of obesity than children with controlled asthma. Stress can affect asthma control, and children with poorly controlled asthma are more likely to have learning disabilities compared with those with good control. In adults, focused attention and concentration are negatively affected in patients with untreated asthma, and patients with asthma are at greater risk for depression. Also, poorly controlled asthma increases the risks of severe asthma exacerbations following upper respiratory and pneumococcal pulmonary infections. ICSs used to improve asthma control have been demonstrated to improve all of these outcomes. Lastly, the risks of uncontrolled asthma during pregnancy are substantially greater than the risks of recommended asthma medications. Treatments to maintain asthma control are the best approach to optimize maternal and fetal health in the pregnancies of women with asthma. The maintenance of asthma control has significant advantages to patients and greatly outweighs the potential risks of treatment side effects. CHEST 2013; 143(2):511-523
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据